Skip to search formSkip to main contentSkip to account menu

monoclonal antibody 3F8

Known as: 3F8 Monoclonal Antibody, 3f8, MOAB 3F8 
A murine monoclonal antibody directed against the cell-surface, tumor-associated antigen ganglioside GD2. Vaccination with monoclonal antibody 3F8… 
National Institutes of Health

Related topics

Related topics

1 relation
antigen binding

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2014
2014
Whole Genome Expression in Mice Containing a Human Mannose Binding Gene (hMBL): Examining the Immunological Role of Monoclonal Antibody (mAb) 3F8 In Attenuating Myocardial Ischemia-Reperfusion…
During a myocardial ischemic event, acute occlusion sets in motion cell necrosis and myocardial tissue injury referred to as a… 
2013
2013
Anti-GD2 antibody 3F8 and barley-derived (1 → 3),(1 → 4)-β-D-glucan
β-glucans are complex, naturally-occurring polysaccharides that prime leukocyte dectin and complement receptor 3. Based on our… 
2012
2012
Monoclonal antibodies against dengue NS2B and NS3 proteins for the study of protein interactions in the flaviviral replication complex.
2007
2007
High‐dose cyclophosphamide inhibition of humoral immune response to murine monoclonal antibody 3F8 in neuroblastoma patients: Broad implications for immunotherapy
The murine monoclonal antibody 3F8 mediates lysis of neuroblastoma (NB) by complement and leukocytes (including neutrophils) but… 
2006
2006
Flow Cytometric Determination of the Frequency and Heterogeneity of Expression of Human Melanoma-associated Antigens 1
We used flow cytometry to measure the expression of human mela noma antigens on cell suspensions dissociated from metastatic… 
Highly Cited
1998
Highly Cited
1998
Antibodies against GD2 ganglioside can eradicate syngeneic cancer micrometastases.
After 10 years of clinical trials in patients with advanced cancer, monoclonal antibodies (mAbs) against cell surface antigens… 
1997
1997
Additive cytotoxicity of different monoclonal antibody-cobra venom factor conjugates for human neuroblastoma cells.
Insufficient numbers of antigen molecules and heterogeneity of antigen expression on tumor cells are major factors limiting the… 
Highly Cited
1994
Highly Cited
1994
Receptor tyrosine phosphatase beta is expressed in the form of proteoglycan and binds to the extracellular matrix protein tenascin.
The extracellular domain of receptor type protein tyrosine phosphatase beta (RPTP beta) exhibits striking sequence similarity… 
1990
1990
Complement killing of human neuroblastoma cells: a cytotoxic monoclonal antibody and its F(ab')2-cobra venom factor conjugate are equally cytotoxic.
1987
1987
Targeting of ganglioside GD2 monoclonal antibody to neuroblastoma.
The biodistribution of 3F8, and IgG3 murine monoclonal antibody (MoAb) specific for the disialoganglioside GD2, was studied in… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)